Vident Investment Advisory’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Vident Investment Advisory’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-74,279	Closed	-$2.17M	–	1002
2018 Q1	$2.17M	Buy	+74,279	New	+$3.12M	0.09%	300

Vident Investment Advisory's ARMO Position: Q2 2018 in Review

Vident Investment Advisory sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 74,279 shares — an estimated $2.17M sold.

Vident Investment Advisory first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $2.17M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Vident Investment Advisory reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Vident Investment Advisory sold 74,279 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $2.17M.
Vident Investment Advisory first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Vident Investment Advisory's ARMO BioSciences, Inc. Common Stock position peaked at $2.17M in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Vident Investment Advisory's 13F filing for Q2 2018, filed 14 Aug 2018.